CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)

Authors :: J. Woyach
Jeffrey P. Sharman
S. Coutre
Priti Patel
Talha Munir
Wojciech Jurczak
V. Banerji
J.C. Byrd
U. Emeribe
M.H. Wang
P. Walker
William G. Wierda
E. Flood
P. Ghia
G. Salles
Source :: Value in Health. 24:S3-S4
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Full Text Access

Tools